BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22900142)

  • 21. miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.
    Ma YS; Yu F; Zhong XM; Lu GX; Cong XL; Xue SB; Xie WT; Hou LK; Pang LJ; Wu W; Zhang W; Cong LL; Liu T; Long HD; Sun R; Sun HY; Lv ZW; Wu CY; Fu D
    Mol Ther; 2018 Dec; 26(12):2751-2765. PubMed ID: 30301667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
    Ng FS; Toh TB; Ting EH; Koh GR; Sandanaraj E; Phong M; Wong SS; Leong SH; Kon OL; Tucker-Kellogg G; Ng WH; Ng I; Tang C; Ang BT
    Clin Cancer Res; 2012 Aug; 18(15):4122-35. PubMed ID: 22675171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
    J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
    Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
    Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
    Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop.
    Shi L; Wang Y; Lu Z; Zhang H; Zhuang N; Wang B; Song Z; Chen G; Huang C; Xu D; Zhang Y; Zhang W; Gao Y
    Oncogene; 2017 Mar; 36(12):1631-1643. PubMed ID: 27869168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer.
    Fang Y; Wang J; Wang G; Zhou C; Wang P; Zhao S; Zhao S; Huang S; Su W; Jiang P; Chang A; Xiang R; Sun P
    Oncotarget; 2017 Apr; 8(16):26702-26717. PubMed ID: 28460458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cancer stem cells in neoplasia of the lung: past, present and future.
    Yagui-Beltrán A; He B; Jablons DM
    Clin Transl Oncol; 2008 Nov; 10(11):719-25. PubMed ID: 19015068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
    Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
    PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis.
    Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-Expression Network Analysis Identified Genes Associated with Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.
    Qin S; Long X; Zhao Q; Zhao W
    Cancer Invest; 2020 Jan; 38(1):13-22. PubMed ID: 31770041
    [No Abstract]   [Full Text] [Related]  

  • 34. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
    Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS
    Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells.
    Vad-Nielsen J; Jakobsen KR; Daugaard TF; Thomsen R; Brügmann A; Sørensen BS; Nielsen AL
    BMC Cancer; 2016 Jan; 16():32. PubMed ID: 26791953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.
    Vad-Nielsen J; Nielsen AL
    Cancer Biol Ther; 2015; 16(2):189-200. PubMed ID: 25588111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.
    Salcido CD; Larochelle A; Taylor BJ; Dunbar CE; Varticovski L
    Br J Cancer; 2010 May; 102(11):1636-44. PubMed ID: 20424609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.
    Oh SJ; Noh KH; Lee YH; Hong SO; Song KH; Lee HJ; Kim S; Kim TM; Jeon JH; Seo JH; Kim DW; Kim TW
    Oncotarget; 2015 Nov; 6(37):40255-67. PubMed ID: 26517679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential.
    Justilien V; Regala RP; Tseng IC; Walsh MP; Batra J; Radisky ES; Murray NR; Fields AP
    PLoS One; 2012; 7(4):e35040. PubMed ID: 22545096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.